Aetna Inc. (AET) Position Trimmed by Howe & Rusling Inc.

Howe & Rusling Inc. lowered its position in Aetna Inc. (NYSE:AET) by 3.7% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 23,544 shares of the company’s stock after selling 898 shares during the period. Howe & Rusling Inc.’s holdings in Aetna were worth $3,744,000 at the end of the most recent quarter.

A number of other institutional investors have also recently modified their holdings of the stock. Guardian Life Insurance Co. of America boosted its holdings in Aetna by 0.7% in the 1st quarter. Guardian Life Insurance Co. of America now owns 1,353 shares of the company’s stock worth $173,000 after buying an additional 9 shares during the period. Financial Architects Inc boosted its holdings in Aetna by 1.8% in the 2nd quarter. Financial Architects Inc now owns 1,746 shares of the company’s stock worth $265,000 after buying an additional 31 shares during the period. Wedbush Securities Inc. boosted its holdings in Aetna by 1.4% in the 2nd quarter. Wedbush Securities Inc. now owns 3,779 shares of the company’s stock worth $574,000 after buying an additional 52 shares during the period. Calamos Wealth Management LLC boosted its holdings in Aetna by 0.7% in the 2nd quarter. Calamos Wealth Management LLC now owns 8,919 shares of the company’s stock worth $1,354,000 after buying an additional 65 shares during the period. Finally, HM Payson & Co. boosted its holdings in Aetna by 0.5% in the 1st quarter. HM Payson & Co. now owns 12,861 shares of the company’s stock worth $1,641,000 after buying an additional 69 shares during the period. 89.52% of the stock is owned by institutional investors.

Several research analysts recently weighed in on AET shares. BidaskClub downgraded shares of Aetna from a “buy” rating to a “hold” rating in a report on Monday, July 31st. Zacks Investment Research downgraded shares of Aetna from a “buy” rating to a “hold” rating in a report on Tuesday, October 3rd. Deutsche Bank AG upped their target price on shares of Aetna from $157.00 to $163.00 and gave the stock a “hold” rating in a report on Monday, August 7th. Royal Bank Of Canada upped their target price on shares of Aetna from $162.00 to $171.00 and gave the stock an “outperform” rating in a report on Friday, August 4th. Finally, Morgan Stanley upped their target price on shares of Aetna from $172.00 to $179.00 and gave the stock an “overweight” rating in a report on Thursday, August 17th. Nine equities research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. The stock presently has a consensus rating of “Buy” and a consensus target price of $161.83.

Shares of Aetna Inc. (NYSE:AET) traded up 2.03% during trading on Friday, hitting $160.84. 1,781,389 shares of the stock were exchanged. The stock’s 50 day moving average price is $158.13 and its 200-day moving average price is $149.69. Aetna Inc. has a one year low of $104.59 and a one year high of $164.52. The company has a market cap of $53.41 billion, a price-to-earnings ratio of 35.70 and a beta of 0.53.

Aetna (NYSE:AET) last released its quarterly earnings results on Thursday, August 3rd. The company reported $3.42 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.34 by $1.08. The business had revenue of $15.52 billion for the quarter, compared to the consensus estimate of $15.34 billion. Aetna had a net margin of 2.52% and a return on equity of 20.52%. The business’s revenue was down 2.7% on a year-over-year basis. During the same period in the previous year, the firm earned $2.21 EPS. On average, analysts predict that Aetna Inc. will post $9.52 EPS for the current year.

The business also recently declared a quarterly dividend, which will be paid on Friday, October 27th. Stockholders of record on Thursday, October 12th will be paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.24%. The ex-dividend date is Wednesday, October 11th. Aetna’s dividend payout ratio (DPR) is 43.67%.

TRADEMARK VIOLATION WARNING: This article was first reported by The Ledger Gazette and is the property of of The Ledger Gazette. If you are viewing this article on another site, it was copied illegally and reposted in violation of US & international copyright & trademark laws. The correct version of this article can be viewed at https://ledgergazette.com/2017/10/20/aetna-inc-aet-position-trimmed-by-howe-rusling-inc.html.

In related news, EVP Margaret M. Mccarthy sold 10,288 shares of the company’s stock in a transaction that occurred on Friday, September 15th. The shares were sold at an average price of $162.85, for a total transaction of $1,675,400.80. Following the sale, the executive vice president now directly owns 33,563 shares of the company’s stock, valued at approximately $5,465,734.55. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, President Karen S. Lynch sold 15,271 shares of the company’s stock in a transaction that occurred on Monday, September 18th. The stock was sold at an average price of $161.91, for a total transaction of $2,472,527.61. Following the sale, the president now directly owns 64,261 shares in the company, valued at $10,404,498.

A number of other institutional investors have also recently modified their holdings of the stock. Guardian Life Insurance Co. of America boosted its holdings in Aetna by 0.7% in the 1st quarter. Guardian Life Insurance Co. of America now owns 1,353 shares of the company’s stock worth $173,000 after buying an additional 9 shares during the period. Financial Architects Inc boosted its holdings in Aetna by 1.8% in the 2nd quarter. Financial Architects Inc now owns 1,746 shares of the company’s stock worth $265,000 after buying an additional 31 shares during the period. Wedbush Securities Inc. boosted its holdings in Aetna by 1.4% in the 2nd quarter. Wedbush Securities Inc. now owns 3,779 shares of the company’s stock worth $574,000 after buying an additional 52 shares during the period. Calamos Wealth Management LLC boosted its holdings in Aetna by 0.7% in the 2nd quarter. Calamos Wealth Management LLC now owns 8,919 shares of the company’s stock worth $1,354,000 after buying an additional 65 shares during the period. Finally, HM Payson & Co. boosted its holdings in Aetna by 0.5% in the 1st quarter. HM Payson & Co. now owns 12,861 shares of the company’s stock worth $1,641,000 after buying an additional 69 shares during the period. 89.52% of the stock is owned by institutional investors.

Several research analysts recently weighed in on AET shares. BidaskClub downgraded shares of Aetna from a “buy” rating to a “hold” rating in a report on Monday, July 31st. Zacks Investment Research downgraded shares of Aetna from a “buy” rating to a “hold” rating in a report on Tuesday, October 3rd. Deutsche Bank AG upped their target price on shares of Aetna from $157.00 to $163.00 and gave the stock a “hold” rating in a report on Monday, August 7th. Royal Bank Of Canada upped their target price on shares of Aetna from $162.00 to $171.00 and gave the stock an “outperform” rating in a report on Friday, August 4th. Finally, Morgan Stanley upped their target price on shares of Aetna from $172.00 to $179.00 and gave the stock an “overweight” rating in a report on Thursday, August 17th. Nine equities research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. The stock presently has a consensus rating of “Buy” and a consensus target price of $161.83.

Shares of Aetna Inc. (NYSE:AET) traded up 2.03% during trading on Friday, hitting $160.84. 1,781,389 shares of the stock were exchanged. The stock’s 50 day moving average price is $158.13 and its 200-day moving average price is $149.69. Aetna Inc. has a one year low of $104.59 and a one year high of $164.52. The company has a market cap of $53.41 billion, a price-to-earnings ratio of 35.70 and a beta of 0.53.

Aetna (NYSE:AET) last released its quarterly earnings results on Thursday, August 3rd. The company reported $3.42 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.34 by $1.08. The business had revenue of $15.52 billion for the quarter, compared to the consensus estimate of $15.34 billion. Aetna had a net margin of 2.52% and a return on equity of 20.52%. The business’s revenue was down 2.7% on a year-over-year basis. During the same period in the previous year, the firm earned $2.21 EPS. On average, analysts predict that Aetna Inc. will post $9.52 EPS for the current year.

The business also recently declared a quarterly dividend, which will be paid on Friday, October 27th. Stockholders of record on Thursday, October 12th will be paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.24%. The ex-dividend date is Wednesday, October 11th. Aetna’s dividend payout ratio (DPR) is 43.67%.

TRADEMARK VIOLATION WARNING: This article was first reported by The Ledger Gazette and is the property of of The Ledger Gazette. If you are viewing this article on another site, it was copied illegally and reposted in violation of US & international copyright & trademark laws. The correct version of this article can be viewed at https://ledgergazette.com/2017/10/20/aetna-inc-aet-position-trimmed-by-howe-rusling-inc.html.

In related news, EVP Margaret M. Mccarthy sold 10,288 shares of the company’s stock in a transaction that occurred on Friday, September 15th. The shares were sold at an average price of $162.85, for a total transaction of $1,675,400.80. Following the sale, the executive vice president now directly owns 33,563 shares of the company’s stock, valued at approximately $5,465,734.55. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, President Karen S. Lynch sold 15,271 shares of the company’s stock in a transaction that occurred on Monday, September 18th. The stock was sold at an average price of $161.91, for a total transaction of $2,472,527.61. Following the sale, the president now directly owns 64,261 shares in the company, valued at $10,404,498.51. The disclosure for this sale can be found here. 0.90% of the stock is currently owned by insiders.

Aetna Profile

Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.

Institutional Ownership by Quarter for Aetna (NYSE:AET)

Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply